PREVENTING OR AMELIORATING AGENT FOR AGE-RELATED COGNITIVE DYSFUNCTION, ENHANCER FOR NEUROTROPHIN 3, PREVENTING OR AMELIORATING AGENT FOR AGE-RELATED DECLINE IN EAGERNESS, AND METHOD FOR PRODUCING THEM

To provide a preventing or ameliorating agent for age-related cognitive dysfunction and to provide an enhancer for neurotrophin 3.SOLUTION: The preventing or ameliorating agent for age-related cognitive dysfunction includes tea leaf or a tea leaf extract being an extract extracted from the tea leaf....

Full description

Saved in:
Bibliographic Details
Main Authors YOSHIDA KATSUSHI, NOMURA SACHIKO, MONOBE MANAMI, NESUMI ATSUSHI, YAMASHITA NAGAYA
Format Patent
LanguageEnglish
Japanese
Published 24.09.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To provide a preventing or ameliorating agent for age-related cognitive dysfunction and to provide an enhancer for neurotrophin 3.SOLUTION: The preventing or ameliorating agent for age-related cognitive dysfunction includes tea leaf or a tea leaf extract being an extract extracted from the tea leaf. In the preventing or ameliorating agent, the tea leaf and the tea leaf extract include non-gallate-type catechin and theogallin and have a ratio of a molar concentration (μmol/L) of theogallin to a molar concentration (μmol/L) of non-gallate-type catechin of 0.3 or more. The enhancer for neurotrophin 3 includes tea leaf and a tea leaf extract being an extract extracted from the tea leaf. In the enhancer for neurotrophin 3, the tea leaf and the tea leaf extract include non-gallate-type catechin and theogallin and have a ratio of a molar concentration (μmol/L) of theogallin to a molar concentration (μmol/L) of non-gallate-type catechin of 0.3 or more.SELECTED DRAWING: Figure 3 【課題】加齢に伴う認知機能障害の予防又は改善剤、及び、ニューロトロフィン3の増強剤を提供すること。【解決手段】茶葉又は該茶葉の抽出物である茶葉抽出物を含む、加齢に伴う認知機能障害の予防又は改善剤であって、前記茶葉及び前記茶葉抽出物は、非ガレート型カテキン及びテオガリンを含み、非ガレート型カテキンのモル濃度(μmol/L)に対するテオガリンのモル濃度(μmol/L)の割合が、0.3以上である、加齢に伴う認知機能障害の予防又は改善剤、及び、茶葉又は該茶葉の抽出物である茶葉抽出物を含む、ニューロトロフィン3の増強剤であって、前記茶葉及び前記茶葉抽出物は、非ガレート型カテキン及びテオガリンを含み、非ガレート型カテキンのモル濃度(μmol/L)に対するテオガリンのモル濃度(μmol/L)の割合が、0.3以上である、ニューロトロフィン3の増強剤。【選択図】図3
Bibliography:Application Number: JP20200046203